Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
The new capability will provide employers with additional choices on how they support their populations, to align with benefit strategy goals and to optimize anti-obesity medication spend and outcomes, executive said
Multiple mechanisms likely contribute: Weight loss: Reduces cardiac workload, improves blood pressure, and improves lipid profiles
Plans should also account for overall health, related health conditions such as high blood pressure or high cholesterol, and whether the goal is to treat obesity
A paper recently published in the Journal of the Endocrine Society (JES) even describes how GLP-1RAs might be used to treat alcohol and drug addictions
US$ 21.08
US$ 22.60
US$ 23.20
US$ 21.95
US$ 23.60
